Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s15006-021-9641-0 | DOI Listing |
J Cardiovasc Comput Tomogr
January 2025
Department of Cardiology, Gødstrup Hospital, Herning, Denmark.
Background: Discrepancies often exist between patient-reported symptoms and diagnostic test findings in patients with suspected obstructive coronary artery disease (CAD).
Objectives: To quantify the association between patient-reported symptoms and the diagnosis of severe stenosis in patients with suspected obstructive CAD.
Methods: Two large-scale cohorts of patients with new-onset symptoms suggestive of obstructive CAD were evaluated.
Background Autonomic dysfunction is associated with adverse outcomes in patients with coronary artery disease. Cardiac autonomic dysfunction parameters such as heart rate variability (HRV) and heart rate recovery (HRR) have been studied individually and have been linked to the presence or likelihood of coronary artery disease. In this study, the cardiac autonomic function was assessed in terms of HRR and HRV.
View Article and Find Full Text PDFInt J Cardiol Cardiovasc Risk Prev
March 2025
Department of Public and Occupational Health, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands.
Objective: While chest pain is a common symptom, its prevalence among women and men across ethnic groups is unknown. Moreover, how chest pain is associated with general practitioner (GP) and cardiologist visits in women and men across ethnic groups, remains to be determined.
Design: We used baseline data on 12423 women and 9071 men from the multi-ethnic HELIUS cohort (Amsterdam, the Netherlands; 2011-2015).
Clin Case Rep
January 2025
Cardiology Unit, Department of Internal Medicine College of Health Sciences, Addis Ababa University Addis Ababa Ethiopia.
Myocardial bridging is a common coronary anomaly. Although it is considered to be a benign condition, it can rarely be complicated by myocardial infarction. Clinicians should be suspicious of myocardial bridging as an etiology of myocardial infarction when other more common etiologies have been excluded.
View Article and Find Full Text PDFPharmaceutics
December 2024
Dipartimento di Farmacia, Salute e Scienze della Nutrizione, Università della Calabria, Arcavacata di Rende, 87036 Cosenza, Italy.
Hypertension affects 32% of adults worldwide, leading to a significant global consumption of cardiovascular medications. Atenolol, a β-adrenergic receptor blocker, is widely prescribed for cardiovascular diseases such as hypertension, angina pectoris, and myocardial infarction. According to the Biopharmaceutics Classification System (BCS), atenolol belongs to Class III, characterized by high solubility but low permeability.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!